Investigating the immune environment of liposarcoma using genetically modified mice
Genetically engineered mouse models to investigate the liposarcoma microenvironment
This study is looking at how certain immune cells, called memory T cells, work in the environment of liposarcoma tumors to find new ways to improve treatment for patients with this type of cancer.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11078329 on NIH RePORTER |
What this research studies
This research focuses on understanding the tumor microenvironment of liposarcoma, a common type of soft tissue cancer, by using genetically engineered mouse models. The study aims to explore the role of memory T cells, particularly resident memory T cells, in the immune response against liposarcoma. By characterizing these immune cells within the tumor, researchers hope to identify new immunotherapeutic strategies that could improve treatment outcomes for patients. The approach involves advanced techniques to analyze the interactions between tumor cells and the immune system in a controlled setting.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with liposarcoma, particularly those with well-differentiated or dedifferentiated subtypes.
Not a fit: Patients with other types of cancer or those who do not have liposarcoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective immunotherapies for patients with liposarcoma.
How similar studies have performed: Previous research has shown promising results in understanding the immune response in other solid tumors, suggesting potential for success in this area as well.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Angeles, Christina Vadala — University of Michigan at Ann Arbor
- Study coordinator: Angeles, Christina Vadala
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.